IAS COVID-19 Conference: Prevention

Featuring the latest in COVID-19 prevention science, policy and practice | 2 February 2021

A vote of thanks!

Now that the IAS COVID-19 Conference: Prevention has drawn to a close, we want to acknowledge the contributions of the Conference Co-chairs and Scientific Committee, our partners in civil society, media, and everyone else who contributed to this historic gathering to discuss the constantly evolving global response to COVID-19!

You volunteered your time, offered your expertise and insights, and supported us wherever you could. So, please accept a big THANK YOU from us to you! Without you, the IAS COVID-19 Conference: Prevention would not have happened.

Speakers

Adeeba Kamarulzaman
President, International AIDS Society

Anthony Fauci
Director, National Institute of Allergy & Infectious Diseases

Beatriz Grinsztejn
Infectious Disease Physician, Researcher, Evandro Chagas National Institute of Infectious Diseases-Oswaldo Cruz Foundation

Fatima Hassan
Founder, Health Justice Initiative

Gabriella Scarlatti
MD, Paediatrician and PhD in Virology, San Raffaele Scientific Institute

Galit Alter
Professor of Medicine, Ragon Institute of MGH, MIT and Harvard

Jennifer Kates
Vice President & Director, Global Health & HIV Policy, Kaiser Family Foundation

Jodie McVernon
Professor and Director, Doherty Institute

Julia Marcus
Associate Professor, Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute

Larry Corey
Fred Hutch

Lidia Morawska
Professor, School of Earth and Atmospheric Sciences, Queensland University of Technology

Linda-Gail Bekker
Chief Operating Officer, Desmond Tutu HIV Foundation

Linfa Wang
Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore

Myron Cohen
Professor University of North Carolina

Peter Sands
Executive Director, The Global Fund

Seth Berkley
CEO, Gavi

Sharon Lewin
Director, Peter Doherty Institute for Infection and Immunity

A committee of six leading scientists will chair this prevention-focused IAS COVID-19 Conference:

Linda-Gail Bekker, (IAS Past President, University of Cape Town)
Susan Buchbinder (IAS Governing Council member, University of California)
Beatriz Grinsztejn (IAS Governing Council member, Fundação Oswaldo Cruz)
Adeeba Kamarulzaman (IAS President, University of Malaya)
Jennifer Kates (IAS Treasurer, Kaiser Family Foundation)
Sharon Lewin (IAS President-Elect, University of Melbourne)

Prevention research submissions to the new conference will be accepted from 27 October to 24 November 2020 in the categories of basic science, vaccines, non-pharmaceutical prevention and global access and policy. Selected oral abstracts and posters will also be included in the programme.

Registration for the IAS COVID-19 Conference: Prevention opens on 4 November 2020. Those registered for the 4th HIV Research for Prevention Conference (HIVR4P // VIRTUAL), hosted during the same period as the COVID-19 Conference, are automatically registered.

“After the first IAS-hosted COVID-19 Conference in July 2020, I am excited to announce the second iteration that will help shape the global pandemic response. Many HIV professionals are currently leading the COVID-19 response in their respective countries and conducting related prevention research. We expect the meeting to further accelerate progress in the face of COVID-19.”

Adeeba KamarulzamanIAS President and conference Co-Chair

“As multiple vaccine trials are being conducted globally, it is essential to take stock, scrutinize efforts to date for their scientific validity, be clear about what works and what doesn’t, and deduct the implications for policymakers around the world.”

Linda-Gail BekkerFormer IAS President and conference Co-Chair

Sign up for COVID-19 Conference news

Join the COVID-19 Conference mailing list to receive the latest news, updates and announcements.